RanD Revenue and Competitors
Estimated Revenue & Valuation
- RanD's estimated annual revenue is currently $6.8M per year.
- RanD's estimated revenue per employee is $251,000
Employee Data
- RanD has 27 Employees.
- RanD grew their employee count by 23% last year.
RanD's People
| Name | Title | Email/Phone |
|---|
RanD Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.1M | 49 | -18% | $10M | N/A |
#2 | $30.4M | 121 | 29% | N/A | N/A |
#3 | $139.8M | 913 | -3% | $200K | N/A |
#4 | $84.1M | 0 | N/A | $1.2M | N/A |
#5 | $43.4M | 173 | 30% | N/A | N/A |
#6 | $64.5M | 257 | 12% | N/A | N/A |
#7 | $64.3M | 205 | 26% | $129.6M | N/A |
#8 | $19.6M | 78 | -7% | N/A | N/A |
#9 | $65.8M | 262 | 7% | N/A | N/A |
#10 | $73.7M | 235 | 20% | $115.5M | N/A |
What Is RanD?
Located in the internationally well-known Mirandola Bio-medical district, RanD is a knowledge-based company, established in 1999 exploiting more than 30 years' experience in the bio-medical field. Over the years RanD developed a whole range of products mainly focused on surgical oncology, but it also exploited its own know-how in the development of third-party cutting-edge projects in the fields of liver support, cardiopulmonary support and dialysis.
keywords:N/A
N/A
Total Funding
27
Number of Employees
$6.8M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RanD News
A South African Rand is seen in this illustration picture taken October 30, 2020. REUTERS/Mike Hutchings/File Photo...
Some analysts say the rand's 2 percent slide against the US dollar is also due to the ongoing uncertainty around the Ukrainian/ Russian war and...
The rand weakened to the lowest in a month against the dollar on Tuesday at midday, as global growth amid the ongoing war in Ukraine and...
Other Companies in Medolla
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $85.8M | 289 | 15% | N/A |
#2 | $55M | 440 | 29% | N/A |